Neurol Clin Pract 2021 Dec;11(6):517-520
University of Vermont (EF), Burlington, VT; University of New Hampshire (AD), Manchester, NH; and Beth Israel Deaconess Medical Center (SM, EM, SF), Boston, MA.
Objective: To determine the impact of percutaneous endoscopic gastrostomy (PEG) tubes in patients with advanced Huntington disease (HD).
Methods: A retrospective chart review of patients with HD was conducted to assess the rate of pneumonia and pressure ulcer, length of life, changes in weight, and serologic nutritional measures. Surviving and deceased patients with and without PEG tubes were compared using descriptive statistical analysis. Read More